Proudly nonprofit. Purposefully driven.

More paths
to recovery.
More life ahead.

Recovery deserves more than one way forward. IBOCare Foundation is a nonprofit bringing rigorous ibogaine research and a full year of human support together.

A nonprofit 501(c)(3) foundation for evidence. A future built around people.

Sunlight reaching a quiet path through a green forest
THE WAY FORWARD

Hope starts with
an open path.

01 / A NEW POSSIBILITY
THE PROPOSED IBOCARE STUDY

Careful research.
Lasting commitment.

60planned participants
12 monthsof continuing support
1Colorado clinical site

Why we exist

Behind every addiction
is a person.
And a life worth reclaiming.

People and families need more evidence, more support, and more possibilities.

IBOCare Foundation exists to help advance research into ibogaine for opioid use disorder. Our focus is a carefully designed clinical study that asks important questions—and stays alongside participants long after a treatment session ends.

We believe new possibilities deserve careful investigation, with people’s safety and dignity at the center.

Meet the foundation

Our nonprofit purpose

For people.
For a better future.

We are proud to be a nonprofit foundation. Our purpose is to advance careful research and sustained recovery support for people and families affected by opioid use disorder.

A mission we can move forward together.

Donors, clinicians, researchers and the wider community all have a part to play. Your support helps make the work possible.

We welcome questions about our plans, governance and charitable documentation.

Meet our nonprofit foundation

Our approach

Hope needs a foundation.
Ours has three.

Good intentions are the beginning.
These are the commitments that guide the work.

01

Science that asks
the hard questions.

A proposed Phase 1/2a study designed to investigate safety and early signals of benefit, with a clear comparison and transparent results.

Explore the research
02

Safety in
every decision.

Specialist screening, monitored clinical admissions and independent oversight are central to the proposed design.

Our safety approach
03

Care that
keeps showing up.

Twelve months of planned follow-up, with daily check-ins and human-led support through SENTINEL.

A year of support
THE IBOCARE STUDY
One important question.
A carefully designed study.
Phase
1/2a

The research

A promising question.
A responsible way to ask it.

Could medically supervised ibogaine, combined with sustained recovery support, offer another way forward for people living with opioid use disorder?

That is the question behind our proposed study. It is an investigation—not a promise of a cure.

  • Three proposed study groups
  • Monitored care and independent safety review
  • The same continuing support for every participant
Inside the clinical study

View the public study record · NCT07871877

Proposed study. Funding and required regulatory and ethics approvals must be in place before treatment begins. Registering interest is not enrollment.

Beyond the treatment room

Recovery doesn’t end
at discharge.

SENTINEL is the proposed year-long support model: a bridge between clinical care and everyday life.

Explore the participant journey
01

Prepare together

Medical screening, informed consent and preparation.

02

Carefully monitored care

Three planned clinical admissions with safety reviews.

03

Stay connected

Daily check-ins and human-led clinical responses.

04

Keep moving forward

Continuing support and follow-up through month 12.

For those who believe in better

Your generosity.
Tomorrow’s evidence.
Someone’s next chapter.

Philanthropy can help turn the proposed study into real answers. From specialist clinical monitoring to a year of follow-up, your support can help make careful research possible.

Explore ways to give

OUR ANCHOR PRIORITY

Fund the research.
Support the whole person.

For major gifts and bank transfers, our team will personally guide you through the next steps.

Thoughtful conversations. Shared purpose.

The people behind the purpose

Experience, humanity,
and a shared commitment.

Meet the proposed team
MF

Melinda Fouts, PhD

Foundation leadership · Lead investigator

Regulatory and FDA/IRB lead in the proposed study team.

CM

Clive Michelsen, MSc

Lead investigator

SENTINEL platform and digital data systems.

GK

Glenn Kotz, MD

Proposed physician principal investigator

Owner of Midvalley Family Practice.

Proposed study roles are drawn from the foundation’s donor briefing. Final appointments are subject to confirmation.

A little more clarity

Questions are
always welcome.

Here are a few good places to start.

Get in touch
Is ibogaine an approved treatment?

Ibogaine is investigational and is not approved by the FDA. The proposed IBOCare study is intended to investigate its safety and early effects under medical supervision. This foundation website does not offer treatment.

Can I join the clinical trial now?

You can express interest in future study updates. That is not enrollment or an eligibility decision. Recruitment and treatment depend on funding and the required approvals.

How can I make a donation?

Visit Ways to give to contact the foundation about a gift or bank-transfer instructions. Online payment processing is not currently offered.

What happens after the treatment sessions?

The proposed design provides every participant with 12 months of follow-up, including monthly clinic visits, daily check-ins and human-led recovery support.

Hope, with a way forward

A better answer begins
with all of us.

Help move careful research and lasting recovery support forward.

Start a conversation

We’d love to hear from you.

Tell us a little about your enquiry. You’ll review your message before opening your email app.

This form prepares an email. Nothing is sent or registered automatically.